What the Latest Research from NKF Annual Conference Means for You

Artificial intelligence (AI) was one of the most talked-about topics at this year's conference.

Researchers and clinicians discussed how AI may help improve the detection and management of kidney disease and acute kidney injury due to its ability to quickly analyze large amounts of health information. This may help healthcare professionals better identify patterns, flag potential problems, and make more informed decisions.

For patients, this could mean earlier identification of kidney problems, more personalized care, and healthcare teams that can spend less time on paperwork and more time focusing on patients.

But one message was clear throughout the conference: AI is a tool, not a replacement for healthcare professionals.

"AI won't replace clinicians, but clinicians using AI may outperform those who do not," said Kianoush B. Kashani, MD, MS, of Mayo Clinic during a featured session.

Experts emphasized that while AI can help organize information and support decision-making, healthcare professionals must use their medical judgment and build trust to best support patients. 

Learn more about the use of AI in kidney care.

Kidney disease affects everyone differently. Two people with the same diagnosis may experience different symptoms, respond differently to treatments, and have different outcomes.

That's why researchers are working toward more personalized approaches to care.

Several presentations highlighted advances in genomics, the study of DNA, and other technologies that allow researchers to study kidney cells in greater detail than ever before. 

By learning more about the specific genes and cells involved in kidney disease, researchers hope to develop treatments that target the underlying causes of disease rather than taking a one-size-fits-all approach.

For patients, this research could one day mean receiving treatments tailored to their unique biology instead of relying on approaches that may work better for some people than others.

While much of this research is still ongoing, experts believe it could help make kidney care more precise, effective, and personalized.

More than 90,000 people in the United States are currently waiting for a kidney transplant. Access to transplantation remains one of the kidney community's greatest challenges.

Several sessions explored advances in transplantation, including xenotransplantation or the transplantation of genetically modified pig kidneys into humans.

Although xenotransplantation is still in the early stages of clinical research, scientists hope it could one day help address the shortage of donor kidneys and reduce wait times for patients in need of a transplant.

For patients and families waiting for a transplant, these advances offer hope that future generations may have more options and spend less time waiting for a life-saving kidney.

Learn more about xenotransplantation.

Despite the excitement surrounding new technology and scientific breakthroughs, many speakers emphasized that healthcare is still fundamentally about people.

Patrick Gee, a kidney transplant recipient and national kidney patient advocate, shared an important reminder during one session.

"Before any prescription or innovation, clinicians must still utilize healing language. You speak to patients in a manner where you respect them and show empathy," Gee said. "That person-to-person human interaction is still key."

Healthcare professionals agreed that empathy, trust, communication, and shared decision-making remain at the heart of quality care. Technology can provide valuable insights, but patients still need healthcare teams who listen, explain, and support them.

This means that even as AI and other technologies become more common, the relationship between patients and their healthcare teams will remain one of the most important parts of quality kidney care.

Another important theme throughout the conference was the growing role of patients in research, education, and healthcare decision-making.

Patients were not just attendees. They participated in discussions, shared their experiences, and helped provide real-world perspectives on emerging treatments and technologies.

For people living with kidney disease, this is an important reminder that your voice matters. Asking questions, sharing your experiences, and participating in decisions about your care can help ensure that healthcare remains focused on what patients need most.

The innovations discussed at SCM may not change care overnight, but they offer an exciting glimpse into the future.

Researchers are working toward a future where kidney disease can be detected earlier, treatments can be tailored to each individual, and more people have access to life-saving transplants. At the same time, healthcare leaders continue to emphasize the importance of compassionate, patient-centered care. 

The takeaway for patients and caregivers is simple: kidney care continues to move forward. The research being conducted today is helping create better options, better outcomes, and more hope for the future.

By sharing new discoveries and learning from one another at SCM, healthcare teams bring the most current knowledge back to the patients they serve.

But you don't have to attend a medical conference to benefit from the latest advances in kidney care. 

You can:

• Ask your healthcare team about new treatments and research related to your condition. 
• Learn more about clinical research studies.
• Advocate for policies that support kidney patients and living donors.

Have questions? Message NKF CARES to get connected to trusted information and support.